UK and EU Food Supplement Regulatory Compliance: Frameworks, Claims, and Novel Foods

Navigating food supplement compliance across the United Kingdom and the European Union requires strict adherence to statutory baselines governing ingredient safety, presentation, and commercial communications. Following the conclusion of the Brexit transition period, regulatory frameworks have progressively diverged. Brand owners, formulators, and contract manufacturers now face distinct administrative regimes overseen by the UK Food Standards Agency (FSA) and Food Standards Scotland (FSS) in Great Britain, and the European Food Safety Authority (EFSA) alongside the European Commission in the EU. Maintaining cross-border compliance demands close alignment with classification thresholds, novel food authorisations, and permitted nutrition and health claims across both jurisdictions. ## Statutory Classification and the Medicinal Borderline Under both UK and EU law, food supplements are defined as concentrated sources of nutrients or other substances with a nutritional or physiological effect, marketed in measured dose forms such as capsules, tablets, pastilles, ampoules, and powder sachets. In Great Britain, the primary legal baseline remains the Food Supplements (England) Regulations 2003 (with parallel statutory instruments in Scotland and Wales), originally transposing EU Directive 2002/46/EC. Food supplements are regulated as specialised foods and are legally distinct from medicinal products. Under both regulatory regimes, any product presented as having properties for preventing, treating, or curing human disease falls under medicines legislation. Borderline determinations are assessed case by case by the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK or national competent authorities across EU Member States. Formulators must ensure that active substance dosages, botanical profiles, and marketing materials remain strictly within nutritional and physiological parameters. ## Novel Food Authorisation Pathways Ingredients without a documented history of significant consumption in the UK or the EU prior to 15 May 1997 fall under novel food statutory controls. Following 1 January 2021, Great Britain established an independent Regulated Products Application Service, severing automatic alignment with Regulation (EU) 2015/2283. As a result, additions to the Union list of novel foods do not confer legal market access in Great Britain (England, Scotland, and Wales), where separate technical dossiers must be submitted to the FSA and FSS. Under the Windsor Framework, Northern Ireland continues to apply EU novel food regulations. Food business operators distributing across both territories must ensure emerging botanical extracts, precision-fermentation ingredients, and synthetic isolates hold explicit domestic authorisations to avoid compliance enforcement or product withdrawals. ## Health Claims and Register Verification Commercial communications detailing the nutritional or physiological benefits of food supplements are subject to pre-market regulatory approval. In the EU, commercial claims are governed by Regulation (EC) No 1924/2006, permitting only claims listed on the EU Register of Health Claims. Great Britain operates the parallel Great Britain Nutrition and Health Claims Register (GB NHCR). While EU-authorised claims adopted prior to 1 January 2021 were retained in domestic law, new claim applications must undergo independent risk assessment by the UK Nutrition and Health Claims Specialist Advisory Group (NHCSAG) before receiving statutory approval from UK health ministers. Compliance requires exact adherence to authorised wording conditions and specific criteria for use. Implied, exaggerated, or misleading health representations remain prohibited across both jurisdictions. Furthermore, brand names or trademarks implying health or wellness benefits must be accompanied on packaging by a corresponding authorised claim from the respective statutory register. ## Quality Assurance and Analytical Verification Regulatory obligations extend across the entire manufacturing supply chain. While Hazard Analysis and Critical Control Point (HACCP) principles represent the statutory minimum under food hygiene regulations, standard commercial trade requires adherence to Good Manufacturing Practice (GMP) principles. Manufacturers must maintain comprehensive batch documentation verifying raw material traceability, botanical identification, pesticide residue limits, microbiological specifications, and heavy metal screening (specifically lead, cadmium, mercury, and inorganic arsenic). In addition, real-time and accelerated stability testing must demonstrate that declared nutrient levels remain within permitted analytical tolerances throughout the product's declared shelf life.